Nova Leap Health Corp
XTSX:NLH
Nova Leap Health Corp
XTSX:NLH
Price:
0.31
CAD
-3.13%
Market Closed
Market Cap:
CA$27.1m
Relative Value
The Relative Value of one
NLH
stock under the Base Case scenario is
0.45
CAD.
Compared to the current market price of 0.31 CAD,
Nova Leap Health Corp
is
Undervalued by 31%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NLH
Relative Value
Base Case
0.45
CAD
Undervaluation 31%
Multiples Across Competitors
NLH Competitors Multiples
Nova Leap Health Corp Competitors
Nova Leap Health Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
Nova Leap Health Corp
XTSX:NLH
|
27.1m CAD | 0.6 | -104.1 | 9.8 | 17.2 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
90.9B USD | 0.2 | 51.4 | 13.4 | 13.4 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
67.4B EUR | 0.3 | 13.1 | 7.7 | 9.8 | |
| US |
|
Cigna Corp
NYSE:CI
|
69.2B USD | 0.3 | 11.6 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
24.6B EUR | 1.1 | 19.4 | 9.3 | 13.8 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.5B EUR | 1.1 | 23 | 8.9 | 16.4 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.6B USD | 1.5 | 24.6 | 11.9 | 17.2 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.5B USD | 1.9 | 21.7 | 11.8 | 15.9 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.5B EUR | 0.5 | 10.8 | 5.2 | 9.7 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.1B USD | 11.3 | -26.7 | -29.3 | -26.6 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.2B USD | 0.8 | 13.7 | 7.1 | 9.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
